FTH peer analysis
Faeth Therapeutics (FTH) against its competitors: price, today's move, 1-year return and market value side by side.
FTH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BOLD Boundless Bio | $2.41 | 0.42% | 73.72% | – |
| JANX Janux | $17.63 | 9.78% | -40.61% | – |
| KURA Kura Oncology | $7.27 | 6.91% | -30.42% | $676.99M |
| KZIA Kazia Therapeutics | $7.16 | 2.29% | -7.05% | $125.63M |
| NUVB Nuvation Bio | $4.19 | 0.00% | -13.46% | – |
| PBYI Puma Biotechnology | $7.96 | -18.51% | 92.86% | $551.82M |
| PRLD Prelude Therapeutics | $3.60 | 1.27% | 101.99% | – |
| RLAY Relay Therapeutics | $18.88 | 11.06% | 147.52% | – |
| TNGX Tango Therapeutics | $21.50 | 3.02% | 160.36% | – |
| VSTM Verastem | $8.40 | -10.45% | 11.13% | $1.20B |
| FTH Faeth Therapeutics | $25.00 | 25.50% | – | – |
- FTH's peers: BOLD (Boundless Bio), JANX (Janux), KURA (Kura Oncology), KZIA (Kazia Therapeutics), NUVB (Nuvation Bio), PBYI (Puma Biotechnology), PRLD (Prelude Therapeutics), RLAY (Relay Therapeutics).
Updated 2026-11-07 11:53 UTC